RNA, U6 small nuclear 961, pseudogene (RNU6-961P)

RNA, U6 small nuclear 961, pseudogene (RNU6-961P) is classified as a human *pseudogene* of the U6 small nuclear RNA gene family. The canonical U6 snRNA is an essential noncoding RNA component of the spliceosome, catalyzing the removal of introns from pre-mRNA during nuclear splicing[1][2]. However, RNU6-961P does not encode a functional snRNA; pseudogenes like this are non-functional remnants of gene duplication or retrotransposition events[3]. While the *authentic* U6 snRNA is highly conserved and critical to splicing, pseudogenes such as RNU6-961P generally do not participate in RNA processing, have no known biological function or disease association, and are not considered drug targets or biomarkers[3]. The sequence of RNU6-961P may bear significant similarity to the original U6 snRNA sequence, but it lacks the necessary elements for proper function and is not expressed as an active component in the cell[3]. Further details: - The true U6 snRNA is central to splicing as part of the spliceosome, where it coordinates magnesium ions required for catalysis and assists in several key RNA-RNA and RNA-protein interactions[1][2]. - Human genomes contain many U6 pseudogenes, which are considered nonfunctional "backups" or evolutionary remnants with high sequence similarity to the functional U6 snRNA gene[2][3]. - Pseudogenes like RNU6-961P do not encode proteins nor functional RNAs, are not classified as therapeutic targets, and have no direct clinical relevance[2][3]. Summary Judgment: RNU6-961P is not a therapeutic target; it is a pseudogene of U6 snRNA. There is no evidence that it encodes a functional molecule or plays a biological role, nor is it targeted by drugs or clinically actionable[1][2][3].

Other names

RNU6-961PU6 snRNA pseudogeneU6 pseudogene